EMA Authorised: Docetaxel Accord (docetaxel) — Accord Healthcare S.L.U.

View source ↗

Summary

The EMA authorised Docetaxel Accord (docetaxel) from Accord Healthcare for multiple cancer indications, including head and neck cancer, non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Breast Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• Docetaxel Accord (docetaxel)

Snippet

Status: Authorised. Therapeutic area: Head and Neck Neoplasms;Carcinoma, Non-Small-Cell Lung;Adenocarcinoma;Prostatic Neoplasms;Breast Neoplasms. MAH: Accord Healthcare S.L.U.. Decision date: 04/02/2025